Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticsPaul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
UCB’s James Musick on embracing digital therapeuticsDigital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Millendo’s Julia Owens on leadership in rare diseasesRare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome. Share XMillendo’s Julia Owens on leadership in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/
Customer experience in pharma: Getting the journey rightAs part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, Share XCustomer experience in pharma: Getting the journey righthttps://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/
Livongo looks to set itself apart from digital health rivalsPaul Tunnah sat down with Livongo’s CEO Zane Burke to discuss how he has applied lessons from bigger Share XLivongo looks to set itself apart from digital health rivalshttps://pharmaphorum.com/views-analysis-digital/livongo-looks-to-set-itself-apart-from-digital-health-rivals/
Pharma highlights from 2019 and a look ahead to 2020Paul Tunnah looks at the trends that defined this year in pharma and what they might mean for Share XPharma highlights from 2019 and a look ahead to 2020https://pharmaphorum.com/views-analysis-patients/pharma-highlights-2019-look-ahead-2020/
Where next for patient centricity in pharma?As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need Share XWhere next for patient centricity in pharma?https://pharmaphorum.com/views-analysis-patients/where-next-for-patient-centricity-in-pharma/
Medical meetings: Blockbuster or Netflix?Paul Tunnah asks whether medical meetings will remain relevant in a digital world, and how they might adapt. Share XMedical meetings: Blockbuster or Netflix?https://pharmaphorum.com/views-and-analysis/medical-meetings-blockbuster-or-netflix/
A pharma guide to digital health, multichannel and digital transformationPaul Tunnah runs through the six key aspects of digital health and how businesses can harness them. It’s that Share XA pharma guide to digital health, multichannel and digital transformationhttps://pharmaphorum.com/views-analysis-sales-marketing/a-pharma-guide-to-digital-health-multichannel-and-digital-transformation/
